TLR7/8/9 Antagonists can be used to inhibit TLR7/8/9 mediated cellular responses, such as activation of immune cells, human PBMCs, murine splenocytes or isolated immune cells (e.g., B cells and pDCs).
TLR7/8/9 Antagonists can be used to inhibit signaling in TLR7/8/9-
expressing recombinant cell lines.
ODN 2088 Control (ODN 2087) is can be used as a sequence control for ODN 20881,2, 4-7
. ODN 2088 Control (ODN 2087) inhibits TLR7 and TLR8 mediated signalling but not TLR9 mediated signalling5